Physiologically based Pharmacokinetic/Pharmacodynamic Modeling (PBPK/PD) of Famotidine in Pregnancy

Documenti analoghi

• Labetalol Dosing in Pregnancy: PBPK/PD and CYP2C19 Polymorphisms
  di: Xiaomei I. Liu, et al.
  Pubblicazione: (2024)
• Dose Ranging in Pediatric Drug Development Trials Submitted to the US FDA 2012–2020
  di: Carlton K. K. Lee, et al.
  Pubblicazione: (2025)
• Indomethacin Pharmacokinetics and Pharmacodynamics in Pregnancies With Preterm Labor: The Need for Dose‐Ranging Trials
  di: Stephen J. Balevic, et al.
  Pubblicazione: (2024)
• In‐Depth Analysis of the Selection of PBPK Modeling Tools: Bibliometric and Social Network Analysis of the Open Systems Pharmacology Community
  di: André Dallmann, et al.
  Pubblicazione: (2024)
• Predicting Clinical Pharmacokinetics/Pharmacodynamics and Impact of Organ Impairment on siRNA‐Based Therapeutics Using a Mechanistic Physiologically‐Based Pharmacokinetic‐Pharmacodynamic Model
  di: Annie Lumen, et al.
  Pubblicazione: (2024)